Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement

作者: Luis Puente-Maestu , Paolo Palange , Richard Casaburi , Pierantonio Laveneziana , François Maltais

DOI: 10.1183/13993003.00745-2015

关键词: Cochrane LibraryBreathingIncremental exerciseMedicineVO2 maxPhysical therapyPulmonary diseaseTest (assessment)MEDLINEInspiratory CapacityPhysical medicine and rehabilitation

摘要: This document reviews 1) the measurement properties of commonly used exercise tests in patients with chronic respiratory diseases and 2) published studies on their utilty and/or evaluation obtained from MEDLINE Cochrane Library searches between 1990 March 2015.Exercise are reliable consistently responsive to rehabilitative pharmacological interventions. Thresholds for clinically important changes performance available several tests. In pulmonary arterial hypertension, 6-min walk test (6MWT), peak oxygen uptake ventilation/carbon dioxide output indices appear be variables most vasodilators. While bronchodilators do not always show relevant effects obstructive disease, high-intensity constant work-rate (endurance) (CWRET) considerably more than incremental 6MWTs. High-intensity CWRETs need standardised reduce interindividual variability. Additional physiological information responsiveness can isotime measurements, particularly inspiratory capacity dyspnoea. Less evidence is endurance shuttle test. Although 6MWT less expensive cardiopulmonary testing, two repetitions needed at baseline. All safe when recommended precautions followed, suggesting that no safer others.

参考文章(313)
D P Lipkin, A J Scriven, T Crake, P A Poole-Wilson, Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ. ,vol. 292, pp. 653- 655 ,(1986) , 10.1136/BMJ.292.6521.653
Martin Johnson, Stephen Thomson, The Role of Exercise Testing in the Modern Management of Pulmonary Arterial Hypertension Diseases. ,vol. 2, pp. 120- 147 ,(2014) , 10.3390/DISEASES2020120
S.M REVILL, S.J SINGH, M.D.L MORGAN, Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD Respiratory Medicine. ,vol. 94, pp. 778- 783 ,(2000) , 10.1053/RMED.2000.0824
Anne E. Holland, Catherine J. Hill, Ian Glaspole, Nicole Goh, Leona Dowman, Christine F. McDonald, Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease Respiratory Medicine. ,vol. 107, pp. 1066- 1072 ,(2013) , 10.1016/J.RMED.2013.04.002
Debora Scorsone, Stefano Bartolini, Riccardo Saporiti, Fulvio Braido, Michele Baroffio, Riccardo Pellegrino, Vito Brusasco, Emanuele Crimi, Does a Low-Density Gas Mixture or Oxygen Supplementation Improve Exercise Training in COPD? Chest. ,vol. 138, pp. 1133- 1139 ,(2010) , 10.1378/CHEST.10-0120
Mario Cazzola, Gian Luca Biscione, Franco Pasqua, Girolmina Crigna, Massimiliano Appodia, Vittorio Cardaci, Luigi Ferri, Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD. Respiratory Medicine. ,vol. 102, pp. 1425- 1430 ,(2008) , 10.1016/J.RMED.2008.04.017
Jordan A. Guenette, Roberto C. Chin, Julia M. Cory, Katherine A. Webb, Denis E. O'Donnell, Inspiratory Capacity during Exercise: Measurement, Analysis, and Interpretation Pulmonary Medicine. ,vol. 2013, pp. 956081- 956081 ,(2013) , 10.1155/2013/956081
ELENA SANTANA SOSA, IRIS F. GROENEVELD, LAURA GONZALEZ-SAIZ, LUIS M. LÓPEZ-MOJARES, JOSÉ R. VILLA-ASENSI, MARÍA I. BARRIO GONZALEZ, STEVEN J. FLECK, MARGARITA PÉREZ, ALEJANDRO LUCIA, Intrahospital Weight and Aerobic Training in Children with Cystic Fibrosis: A Randomized Controlled Trial Medicine and Science in Sports and Exercise. ,vol. 44, pp. 2- 11 ,(2012) , 10.1249/MSS.0B013E318228C302
JC Waterhouse, SJ Walters, Y Oluboyede, RA Lawson, A randomised 2 x 2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up. Health Technology Assessment. ,vol. 14, ,(2010) , 10.3310/HTA14060
E.F. Mc Kone, S.C. Barry, M.X. Fitz Gerald, C.G. Gallagher, Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis. Chest. ,vol. 116, pp. 363- 368 ,(1999) , 10.1378/CHEST.116.2.363